Korean Journal of Radiology

  • 제22권7호
  • /
  • Pages.1044-1053
  • /
  • 2021
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Free-Breathing Motion-Corrected Single-Shot Phase-Sensitive Inversion Recovery Late-Gadolinium-Enhancement Imaging: A Prospective Study of Image Quality in Patients with Hypertrophic Cardiomyopathy

  • Min Jae Cha (Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Iksung Cho (Division of Cardiology, Department of Internal medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Joonhwa Hong (Department of Thoracic and Cardiovascular Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Sang-Wook Kim (Division of Cardiology, Department of Internal medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Seung Yong Shin (Division of Cardiology, Department of Internal medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ;
  • Mun Young Paek (Siemens Healthineers Ltd.) ;
  • Xiaoming Bi (Siemens Medical Solutions USA, Inc.) ;
  • Sung Mok Kim (Department of Radiology, Samsung Medical Center, Sungkyunkwan University College of Medicine)
  • 투고 : 2020.06.30
  • 심사 : 2020.12.09
  • 발행 : 2021.07.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: Motion-corrected averaging with a single-shot technique was introduced for faster acquisition of late-gadolinium-enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging while free-breathing. We aimed to evaluate the image quality (IQ) of free-breathing motion-corrected single-shot LGE (moco-ss-LGE) in patients with hypertrophic cardiomyopathy (HCM). Materials and Methods: Between April and December 2019, 30 patients (23 men; median age, 48.5; interquartile range [IQR], 36.5-61.3) with HCM were prospectively enrolled. Breath-held single-shot LGE (bh-ss-LGE) and free-breathing moco-ss-LGE images were acquired in random order on a 3T MR system. Semi-quantitative IQ scores, contrast-to-noise ratios (CNRs), and quantitative size of myocardial scar were assessed on pairs of bh-ss-LGE and moco-ss-LGE. The mean ± standard deviation of the parameters was obtained. The results were compared using the Wilcoxon signed-rank test. Results: The moco-ss-LGE images had better IQ scores than the bh-ss-LGE images (4.55 ± 0.55 vs. 3.68 ± 0.45, p < 0.001). The CNR of the scar to the remote myocardium (34.46 ± 11.85 vs. 26.13 ± 10.04, p < 0.001), scar to left ventricle (LV) cavity (13.09 ± 7.95 vs. 9.84 ± 6.65, p = 0.030), and LV cavity to remote myocardium (33.12 ± 15.53 vs. 22.69 ± 11.27, p < 0.001) were consistently greater for moco-ss-LGE images than for bh-ss-LGE images. Measurements of scar size did not differ significantly between LGE pairs using the following three different quantification methods: 1) full width at half-maximum method; 23.84 ± 12.88% vs. 24.05 ± 12.81% (p = 0.820), 2) 6-standard deviation method, 15.14 ± 10.78% vs. 15.99 ± 10.99% (p = 0.186), and 3) 3-standard deviation method; 36.51 ± 17.60% vs. 37.50 ± 17.90% (p = 0.785). Conclusion: Motion-corrected averaging may allow for superior IQ and CNRs with free-breathing in single-shot LGE imaging, with a herald of free-breathing moco-ss-LGE as the scar imaging technique of choice for clinical practice.

키워드

과제정보

The authors appreciate the technical assistance of Bon Chul Ha, Min Gu Kim, Chul Lee, Sang Hoon Lee, and Hyeong Ho So for helping with MRI scans.

참고문헌

  1. Saeed M, Weber O, Lee R, Do L, Martin A, Saloner D, et al. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media. J Am Coll Cardiol 2006;48:1961-1968 https://doi.org/10.1016/j.jacc.2006.03.071
  2. Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:30
  3. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson 2016;18:6
  4. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15:91
  5. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e212-e260 https://doi.org/10.1016/j.jacc.2011.06.011
  6. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e783-e831
  7. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-2779 https://doi.org/10.1093/eurheartj/ehu284
  8. Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, et al. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:17
  9. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012;5:370-377 https://doi.org/10.1016/j.jcmg.2011.11.021
  10. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223 https://doi.org/10.1148/radiology.218.1.r01ja50215
  11. Sievers B, Rehwald WG, Albert TS, Patel MR, Parker MA, Kim RJ, et al. Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines. Radiology 2008;247:106-114 https://doi.org/10.1148/radiol.2471070132
  12. Kellman P, Larson AC, Hsu LY, Chung YC, Simonetti OP, McVeigh ER, et al. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 2005;53:194-200 https://doi.org/10.1002/mrm.20333
  13. Ledesma-Carbayo MJ, Kellman P, Hsu LY, Arai AE, McVeigh ER. Motion corrected free-breathing delayed-enhancement imaging of myocardial infarction using nonrigid registration. J Magn Reson Imaging 2007;26:184-190 https://doi.org/10.1002/jmri.20957
  14. Kellman P, Xue H, Hansen MS. Free-breathing late enhancement imaging: phase sensitive inversion recovery (PSIR) with respiratory motion corrected (MOCO) averaging. Magnetom Flash 2016;66:65-73
  15. Piehler KM, Wong TC, Puntil KS, Zareba KM, Lin K, Harris DM, et al. Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients. Circ Cardiovasc Imaging 2013;6:423-432 https://doi.org/10.1161/CIRCIMAGING.112.000022
  16. Mikami Y, Kolman L, Joncas SX, Stirrat J, Scholl D, Rajchl M, et al. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2014;16:85
  17. Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150-156 https://doi.org/10.1016/j.jcmg.2010.11.015
  18. Landis JR, Koch GG. A one-way components of variance model for categorical data. Biometrics 1977:671-679
  19. Crewson PE. Reader agreement studies. AJR Am J Roentgenol 2005;184:1391-1397 https://doi.org/10.2214/ajr.184.5.01841391
  20. Fan H, Li S, Lu M, Yin G, Yang X, Lan T, et al. Myocardial late gadolinium enhancement: a head-to-head comparison of motion-corrected balanced steady-state free precession with segmented turbo fast low angle shot. Clin Radiol 2018;73:593. e1-593.e9
  21. Captur G, Lobascio I, Ye Y, Culotta V, Boubertakh R, Xue H, et al. Motion-corrected free-breathing LGE delivers high quality imaging and reduces scan time by half: an independent validation study. Int J Cardiovasc Imaging 2019;35:1893-1901 https://doi.org/10.1007/s10554-019-01620-x
  22. Muehlberg F, Arnhold K, Fritschi S, Funk S, Prothmann M, Kermer J, et al. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial. J Cardiovasc Magn Reson 2018;20:13
  23. Kellman P, Arai AE. Cardiac imaging techniques for physicians: late enhancement. J Magn Reson Imaging 2012;36:529-542 https://doi.org/10.1002/jmri.23605
  24. Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 2020;22:17
  25. Kellman P, Xue H, Olivieri LJ, Cross RR, Grant EK, Fontana M, et al. Dark blood late enhancement imaging. J Cardiovasc Magn Reson 2016;18:77
  26. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-2743 https://doi.org/10.1161/CIRCULATIONAHA.105.570648